Posted inMetabolism, New Drugs, Regulatory Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
